about
Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma.Dose painting based on tumor uptake of Cu-ATSM and FDG: a comparative study.Patterns of failure for patients with glioblastoma following O-(2-[18F]fluoroethyl)-L-tyrosine PET- and MRI-guided radiotherapy.Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials.A new method to estimate doses to the normal tissues after past extended and involved field radiotherapy for Hodgkin lymphoma.Clinical PET/MRI in neurooncology: opportunities and challenges from a single-institution perspective.Minimizing late effects for patients with mediastinal Hodgkin lymphoma: deep inspiration breath-hold, IMRT, or both?Early changes in perfusion of glioblastoma during radio- and chemotherapy evaluated by T1-dynamic contrast enhanced magnetic resonance imaging.Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma
P50
Q35788602-2394C5F6-2A8C-468B-BA70-EFCE8EBE3D32Q38418282-03C05C15-DD17-493B-8318-9F454C6DF43EQ39006909-EEC88FC1-CA10-4031-AFEE-D6EF60469B11Q40190437-971467FC-ABE7-40B6-B57E-4EA18DE2973FQ41529005-D22C8C1B-7FF7-4ED3-A25F-11442EDAF658Q41594601-310FDAD8-FE5B-43E7-AB02-3FECB8E3A8C2Q51046997-DD3AD018-5B23-4AA2-A3D5-E49D3F8BD138Q55459955-C4E6A0C1-BA4C-49C4-B1E1-861B37834813Q57045937-1313D41C-AE4D-46AF-95A6-145C0BDEEAF0
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michael Lundemann
@ast
Michael Lundemann
@en
Michael Lundemann
@es
Michael Lundemann
@nl
Michael Lundemann
@sl
type
label
Michael Lundemann
@ast
Michael Lundemann
@en
Michael Lundemann
@es
Michael Lundemann
@nl
Michael Lundemann
@sl
prefLabel
Michael Lundemann
@ast
Michael Lundemann
@en
Michael Lundemann
@es
Michael Lundemann
@nl
Michael Lundemann
@sl
P106
P108
P1153
56491326700
P31
P496
0000-0002-4216-5757